Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.365
+0.005 (1.28%)
Mar 9, 2026, 3:44 PM EDT - Market open
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $2.75 million as of March 9, 2026. Its market cap has decreased by -92.62% in one year.
Market Cap
2.75M
Enterprise Value
-4.43M
1-Year Change
-92.62%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $2.75M, a decrease of -99.00%. That is a compound annual growth rate of -65.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.64M | -69.17% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XORTX Therapeutics | 3.05M |
| Dermata Therapeutics | 2.98M |
| Azitra | 2.92M |
| Scinai Immunotherapeutics | 2.71M |
| Enveric Biosciences | 2.70M |
| Propanc Biopharma | 2.68M |
| Jaguar Health | 2.68M |
| 60 Degrees Pharmaceuticals | 2.64M |